Open Government Portal
The Guidance Document: Fees for the Review of Drug Submissions and Applications has been updated. The Document Change Log has …
The attached policy has been developed to provide for the filing of Supplemental New Drug Submissions, Supplemental Abbreviated New Drug …
This document is intended to provide Industry with guidance for the preparation of drug submissions for Biotechnological/ Biological Products. It …
This page provides information to assist veterinary drug manufacturers (sponsors) in preparing a well-structured DIN submission to facilitate screening and …
Priority Review is a fast-track status granted to eligible new drug submissions for human use, following review and approval of …
Administrative Corrections to Health Canada's Priority Review Documents. Administrative changes were made to the French and Englishs version of the …
Appearance by the Minister of Employment, Workforce Development and Disability Inclusion, Carla Qualtrough, and Deputy Minister Tremblay, before the Standing …
Appearance by the Minister of Minister of Families, Children and Social Development, Karina Gould, before the Standing Committee on Human …
Briefing package for the Privacy Commissioner of Canada as witness before the Standing Committee on Access to Information, Privacy, and …
This document introduces Health Canada's initiative to publicly release clinical information concerning the safety and efficacy of drugs and safety …